| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.17B | -2.1% |
| Cost of Revenue | $2.29B | -3.7% |
| R&D Expense | $471.0M | +6.3% |
| SG&A Expense | $1.70B | +2.2% |
| Interest Expense | $422.0M | +63.6% |
| Pre-tax Income | $1.12B | -26.6% |
| Income Tax | $205.0M | +15.2% |
| Net Income | $917.0M | -32.1% |
| EPS (Basic) | $3.61 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $706.0M | -4.2% |
| Accounts Receivable | $1.48B | +6.7% |
| Inventory | $1.00B | +9.6% |
| Current Assets | $3.93B | +4.5% |
| Total Assets | $10.96B | +2.6% |
| Current Liabilities | $2.51B | -3.3% |
| Long-term Debt | $8.91B | -2.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $196.0M | +2.1% |
| -32.3% |
| EPS (Diluted) | $3.59 | -32.4% |
| Stockholders' Equity |
| -$892.0M |
| +40.8% |